d‐amphetamine‐induced increase in neurotensin and neuropeptide Y outflow in the ventral striatum is mediated via stimulation of dopamine D1 and D2/3 receptors

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neuroscience Research

• Publication date

  2002-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/JNR.10276PMID 12111825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions

  2004cited by this paper
• Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons

  2004cited by this paper
• Effects of Haloperidol and Risperidone on Neurotensin Levels in Brain Regions and Neurotensin Efflux in the Ventral Striatum of the Rat

  2002cited by this paper
• Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum

  2000cited by this paper
• Endogenous DA‐mediated feedback inhibition of DA neurons: Involvement of both D1‐ and D2‐like receptors

  2000cited by this paper
• Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway.

  1999cited by this paper
• Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.

  1999cited by this paper
• Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice

  1999cited by this paper
• Effects of Stimulants of Abuse on Extrapyramidal and Limbic Neuropeptide Y Systems 1

  1999cited by this paper
• Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.

  1999cited by this paper
• Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.

  1998cited by this paper
• Distinct and interactive effects of d‐amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat

  1998cited by this paper
• Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor.

  1998cited by this paper
• Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems.

  1997cited by this paper
• Role of dopamine D1- and NMDA receptors in regulating neurotensin release in the striatum and nucleus accumbens.

  1997cited by this paper
• Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum.

  1997cited by this paper
• Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.

  1996cited by this paper
• Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis.

  1996cited by this paper
• Striatal interneurones: chemical, physiological and morphological characterization.

  1995cited by this paper
• Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat.

  1995cited by this paper
• An inhibitory dopaminergic regulation of the neuropeptide Y immunoreactivity expression in the rat cerebral cortex neurons.

  1995cited by this paper
• Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats.

  1995cited by this paper
• Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions.

  1994cited by this paper
• Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat.

  1994cited by this paper
• Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity.

  1994cited by this paper
• Neurochemical effects of neuropeptide Y (NPY) and NPY2-36.

  1994cited by this paper
• Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.

  1993cited by this paper
• Neurotransmitter regulation of dopamine neurons in the ventral tegmental area.

  1993cited by this paper
• Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat.

  1993cited by this paper
• Atypical neuroleptic-like behavioral effects of neurotensin.

  1993cited by this paper
• Modulation of the neurotensin striato-nigral pathway by D1 receptors.

  1993cited by this paper
• Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex.

  1992cited by this paper
• Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum.

  1992cited by this paper
• Neurotensin, Antipsychotic Drugs, and Schizophrenia

  1992cited by this paper
• Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen.

  1992cited by this paper
• The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: an in vivo microdialysis study.

  1992cited by this paper
• Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies.

  1992cited by this paper
• Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

  1991cited by this paper
• Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neurons.

  1991cited by this paper
• Effects of centrally administered neuropeptide Y (NPY) and NPY13–36 on the brain monoaminergic systems of the rat

  1990cited by this paper
• Cortical Regulation of Striatal Neuropeptide Y (NPY)‐Containing Neurons in the Rat

  1990cited by this paper
• Neuropeptide Y in Cortex and Striatum

  1990cited by this paper
• Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.

  1990cited by this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cited by this paper
• Ultrastructural features of NPY-containing neurons in the rat striatum.

  1989cited by this paper
• Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways.

  1989cited by this paper
• Effects of dopamine depletion on striatal neurotensin: biochemical and immunohistochemical studies

  1989cited by this paper
• Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum.

  1989cited by this paper
• Neuropeptide Y in the cerebral cortex and the caudate-putamen nuclei: ultrastructural basis for interactions with GABAergic and non-GABAergic neurons

  1989cited by this paper
• Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.

  1988cited by this paper
• The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus.

  1987cited by this paper
• Neurotensin receptor binding sites in monkey and human brain: Autoradiographic distribution and effects of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine treatment

  1987cited by this paper
• Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence.

  1986cited by this paper
• Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.

  1985cited by this paper
• Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons

  1984cited by this paper

• Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder

  2017cites this paper
• Effects of drugs of abuse on the central neuropeptide Y system

  2016cites this paper
• Gene-environment interactions in a rat model of depression. Maternal separation affects neurotensin in selected brain regions.

  2016cites this paper
• Liquid Chromatography-Mass Spectrometry Strategies for in vivo Neurochemical Monitoring with Microdialysis.

  2016cites this paper
• An ultrasensitive nano UHPLC-ESI-MS/MS method for the quantification of three neuromedin-like peptides in microdialysates.

  2015cites this paper
• Elucidating the Role of Neurotensin in the Pathophysiology and Management of Major Mental Disorders

  2014cites this paper
• Striatal NTS1, dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release – a dual‐probe microdialysis study in the intranigral 6‐hydroxydopamine unilaterally lesioned rat

  2012cites this paper
• Effects of olanzapine on extracellular concentrations and tissue content of neurotensin in rat brain regions.

  2011cites this paper
• Effects of neurotensin gene knockout in mice on the behavioral effects of cocaine

  2011cites this paper
• Assessment of the integrative roles of the intergeniculate leaflet in circadian timing and reward pathways

  2011cites this paper
• On the intrinsic regulation of neuropeptide Y release in the mammalian suprachiasmatic nucleus circadian clock

  2010cites this paper
• Effect of total isoflavones from pueraria lobata on the expressions of preproenkephalin, prodynorphin and D2 dopamine receptor mRNA in PC12 cells induced by MPP+

  2010cites this paper
• Brain neurotensin, psychostimulants, and stress--emphasis on neuroanatomical substrates.

  2006cites this paper
• Interactions between dopamine, serotonin, and other reward factor

  2006cites this paper
• Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.

  2006cites this paper
• Effects of maternal separation on neuropeptide Y and calcitonin gene-related peptide in "depressed" Flinders Sensitive Line rats: a study of gene-environment interactions.

  2006cites this paper
• Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats.

  2006cites this paper
• Multitasking with neurotensin in the central nervous system

  2005cites this paper
• Endogenous Neurotensin in the Ventral Tegmental Area Contributes to Amphetamine Behavioral Sensitization

  2005influential citation
• Amphetamine-induced effects on neuropeptide Y in the rat brain.

  2005cites this paper
• Review Multitasking with neurotensin in the central nervous system

  2005cites this paper
• Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.

  2002cites this paper